Northwest Biotherapeutics (NWBO) Financial Statements

Northwest Biotherapeutics's market cap is currently $363.60M. The company's EPS TTM is $-0.068; its P/E ratio is -3.58; Northwest Biotherapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.